| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Amneal Pharmaceuticals Inc (NYSE: AMRX)
AMRX Technical Analysis
5
| As on 9th Jun 2023 AMRX STOCK Price closed @ 2.44 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.43 & Strong Sell for SHORT-TERM with Stoploss of 4.59 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AMRXSTOCK Price
| Open | 2.42 | Change | Price | % |
| High | 2.53 | 1 Day | 0.04 | 1.67 |
| Low | 2.38 | 1 Week | 0.10 | 4.27 |
| Close | 2.44 | 1 Month | 0.62 | 34.07 |
| Volume | 891204 | 1 Year | -2.23 | -47.75 |
| 52 Week High 5.09 | 52 Week Low 1.27 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| AMRX Daily Charts |
AMRX Intraday Charts |
Whats New @ Bazaartrend |
AMRX Free Analysis |
|
|
AMRX Important Levels Intraday
| RESISTANCE | 2.73 |
| RESISTANCE | 2.64 |
| RESISTANCE | 2.58 |
| RESISTANCE | 2.52 |
| SUPPORT | 2.36 |
| SUPPORT | 2.30 |
| SUPPORT | 2.24 |
| SUPPORT | 2.15 |
AMRX Forecast May 2024
| 4th UP Forecast | 4 |
| 3rd UP Forecast | 3.5 |
| 2nd UP Forecast | 3.19 |
| 1st UP Forecast | 2.88 |
| 1st DOWN Forecast | 2 |
| 2nd DOWN Forecast | 1.69 |
| 3rd DOWN Forecast | 1.38 |
| 4th DOWN Forecast | 0.88 |
AMRX Weekly Forecast
| 4th UP Forecast | 3.11 |
| 3rd UP Forecast | 2.90 |
| 2nd UP Forecast | 2.76 |
| 1st UP Forecast | 2.63 |
| 1st DOWN Forecast | 2.25 |
| 2nd DOWN Forecast | 2.12 |
| 3rd DOWN Forecast | 1.98 |
| 4th DOWN Forecast | 1.77 |
AMRX Forecast2024
| 4th UP Forecast | 9.94 |
| 3rd UP Forecast | 7.53 |
| 2nd UP Forecast | 6.05 |
| 1st UP Forecast | 4.56 |
| 1st DOWN Forecast | 0.32 |
| 2nd DOWN Forecast | -1.17 |
| 3rd DOWN Forecast | -2.65 |
| 4th DOWN Forecast | -5.06 |
Amneal Pharmaceuticals Inc ( NYSE USA Symbol : AMRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AMRX Business Profile
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey. Address: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service